Rocket Pharmaceuticals Inc buy BiotechBee
Start price
26.10.22
/
70%
€17.96
Target price
31.12.24
€28.00
Performance (%)
19.30%
Price
13.05.24
?
Summary
This prediction is currently active. The BUY prediction by BiotechBee currently has a performance of 19.30%. This prediction currently runs until 31.12.24. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Rocket Pharmaceuticals Inc | -0.523% | -0.523% | 35.591% |
iShares Core DAX® | 1.662% | 4.835% | 17.361% |
iShares Nasdaq 100 | 0.667% | 0.000% | 38.234% |
iShares Nikkei 225® | -2.139% | -4.786% | 13.099% |
iShares S&P 500 | 0.564% | 0.775% | 29.181% |
According to BiotechBee what are the pros and cons of Rocket Pharmaceuticals Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Rocket Pharmaceuticals Inc diskutieren
Buy mit Kursziel 28,0